Research theme for competitive and other funds (2)：
2018 - 2022 Liver cancer research in non-alcoholic fatty liver disease
2017 - 2020 Evaluation of the role of gut-microbiota in NASH-associated HCC pathogenesis
Papers (172)：
Suguru Kurokawa, Takuro Kobori, Masato Yoneda, Yuji Ogawa, Yasushi Honda, Takaomi Kessoku, Kento Imajo, Satoru Saito, Atsushi Nakajima, Kikuko Hotta. Identification of differentially methylated regions associated with both liver fibrosis and hepatocellular carcinoma. BMC gastroenterology. 2024. 24. 1. 57-57
Michihiro Iwaki, Takaomi Kessoku, Kosuke Tanaka, Anna Ozaki, Yuki Kasai, Takashi Kobayashi, Asako Nogami, Yasushi Honda, Yuji Ogawa, Kento Imajo, et al. Combined, elobixibat, and colestyramine reduced cholesterol toxicity in a mouse model of metabolic dysfunction-associated steatotic liver disease. Hepatology communications. 2023. 7. 11
Takashi Kobayashi, Michihiro Iwaki, Asako Nogami, Nobuyoshi Kawamura, Yasushi Honda, Yuji Ogawa, Kento Imajo, Masato Yoneda, Satoru Saito, Atsushi Nakajima. Prediction of outcomes in patients with metabolic dysfunction-associated steatotic liver disease based on initial measurements and subsequent changes in magnetic resonance elastography. Journal of gastroenterology. 2023
Kento Imajo, Yusuke Saigusa, Takashi Kobayashi, Koki Nagai, Shinya Nishida, Nobuyoshi Kawamura, Hiroyoshi Doi, Michihiro Iwaki, Asako Nogami, Yasushi Honda, et al. M-PAST score is better than MAST score for the diagnosis of active fibrotic NASH. Hepatology research : the official journal of the Japan Society of Hepatology. 2023. 53. 9. 844-856
Takashi Kobayashi, Michihiro Iwaki, Asako Nogami, Yasushi Honda, Yuji Ogawa, Kento Imajo, Satoru Saito, Atsushi Nakajima, Masato Yoneda. Involvement of Periodontal Disease in the Pathogenesis and Exacerbation of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis: A Review. Nutrients. 2023. 15. 5
Takaomi Kessoku, Takashi Kobayashi, Michihiro Iwaki, Anna Ozaki, Kento Imajo, Yasushi Honda, Takuma Higurashi, Yuji Ogawa, Masato Yoneda, Haruki Usuda, et al. EFFECT OF CHOLESTYRAMINE ON MICE MODEL OF NONALCOHOLIC STEATOHEPATITIS WITH INCREASED GUT PERMEABILITY. HEPATOLOGY. 2019. 70. 1299A-1299A
